NICE's severity modifiers misalign with public preferences in England & Wales, prioritising health gains at lower disease ...

More collaborative initiatives are taking place among regulatory agencies, health technology assessment bodies and between ...

Ting (Tina) Wang is Associate Director, HTA Programme and Strategic Partnerships at the Centre for Innovation in Regulatory Science (CIRS). Tina leads CIRS’ work on HTA strategy and research as part ...